# Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease

> **NCT04434365** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 24 (actual)

## Conditions studied

- Stable Coronary Artery Disease
- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Berberine
- **DRUG:** Aspirin
- **DRUG:** Clopidogrel
- **DRUG:** Statin

## Key facts

- **NCT ID:** NCT04434365
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-21
- **Primary completion:** 2019-11-18
- **Final completion:** 2020-12-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04434365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04434365, "Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04434365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*